drop glp 1 GLP-1 Agonists Show Promise in Reducing Glaucoma Risk in Patients with Diabetes GLP-1 Drops for Women and

Antipsychotic-induced weight gain: a comprehensive research synthesis

Self-funded plans frequently exclude weight-loss medications even when the Cigna formulary lists them

As the use of these agents continues to expand, perioperative clinicians are increasingly encountering patients receiving medications such as semaglutide, liraglutide, dulaglutide, and tirzepatide before surgical and procedural interventions

This is one reason scale weight alone becomes an unreliable marker of metabolic health in midlife women

These factors can shape not only which medications are prescribed, but also whether patients remain on therapy or transition to alternatives